Adult population: Metoclopramide is indicated in adults for: Prevention of delayed chemotherapy induced nausea and vomiting (CINV).
Prevention of radiotherapy induced nausea and vomiting (RINV).
Symptomatic treatment of nausea and vomiting, including acute migraine induced nausea and vomiting.
Paediatric population: Metoclopramide is indicated in children (aged 1-18 years) for: Prevention of delayed chemotherapy induced nausea and vomiting (CINV) as a second line option.